Back to results
CompletedPhase 2

Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in Japan

NCT01263496

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in Japan — TrialFind